Pathway analysis approaches for rare and common variants: Insights from genetic analysis workshop 18

Genetic Epidemiology

Volumn 38, Issue SUPPL.1, 2014, Pages

  Aslibekyan, Stella ^a   Almeida, Marcio ^b   Tintle, Nathan ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c DORDT COLLEGE   (United States)

Author keywords

Family studies; Hypertension; Pathway analysis; Whole genome sequence

Indexed keywords

ARTICLE; FAMILY STUDY; FOLLOW UP; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; MOLECULAR GENETICS; PHENOTYPE; UNITED STATES;

FAMILY STUDIES; HYPERTENSION; PATHWAY ANALYSIS; WHOLE-GENOME SEQUENCE;

GENE FREQUENCY; GENETIC VARIATION; GENOME, HUMAN; GENOTYPE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; HYPERTENSION; MODELS, GENETIC; PEDIGREE; PHENOTYPE; SEQUENCE ANALYSIS, DNA;

EID: 84905714207     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.21831     Document Type: Article

References (26)

1. Almasy L, Dyer TD, Peralta JM, Jun G, Wood AR, Fuchsberger C, Almeida MA, Kent JW Jr, Fowler S, Blackwell TW and others. 2014. Data for Genetic Analysis Workshop 18: human whole-genome sequence, blood pressure, and simulated phenotypes in extended pedigrees. BMC Proc 8(Suppl 1):S2.
2. Almeida MMM, Peralta JM, Farook V, Puppala S, Kent JW Jr, Duggirala R, Blangero J. 2014. Pedigree-based random effect tests to screen gene pathways. BMC Proc 8(Suppl 1):S100.
3. Alsulami H, Liu X, Beyene J. 2014. Pathway-based analysis of rare and common variants to test for association with blood pressure. BMC Proc 8(Suppl 1):S101.
4. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT and others. 2000. Gene Ontology: Tool for the unification of biology. Nat Genet 25:25-29.
5. Aslibekyan S, Wiener H, Wu G, Zhi D, Shrestha S, De los Campus G, Vazquez A. 2014. Estimating proportions of explained variance: a comparison of whole-genome subsets. BMC Proc 8(Suppl 1):S102.
6. Croft D, O'Kelly G, Wu G, Haw R, Gillespie M, Matthews L, Caudy M, Garapati P, Gopinath G, Jassal B and others. 2010. Reactome: A database of reactions, pathways, and biological processes. Nucleic Acids Res 39:D691-D697.
7. Dufresne L, Oualkacha K, Forgetta V, Greenwood CMT. 2014. Pathway analysis for genetic association studies: To do or not to do, that is the question. BMC Proc 8(Suppl 1):S103.
8. Edwards J, Atlas S, Wilson S, Cooper C, Luo L, Stidley C. 2014. Integrated statistical and pathway approach to next-generation sequencing analysis: a family-based study of hypertension. BMC Proc 8(Suppl 1):S104.
9. ENCODE Project Consortium. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489:57-74.
10. Greco B, Luedtke A, Hainline A, Alvarez C, Beck A, Tintle NL. 2014. Application of family-based tests of association for rare variants to pathways. BMC Proc 8(Suppl 1):S105.
11. Hu P, Paterson AD. 2014. Dynamic pathway analysis of genes associated with blood pressure using whole-genome sequence data. BMC Proc 8(Suppl 1):S105.
12. Hu P, Xu W, Cheng L, Xing X, Paterson AD. 2011. Pathway-based joint effects analysis of rare genetic variants using Genetic Analysis Workshop 17 exon sequence data. BMC Proc 5(Suppl 9):S45.
13. Iwama H, Gojobori T. 2004. Highly conserved upstream sequences for transcription factor genes and implications for the regulatory network. Proc Natl Acad Sci USA 101(49):17156-17161.
14. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. 2012. KEGG for integration and interpretation of large-scale molecular datasets. Nucleic Acids Res 40:D109-D114.
15. Khatri P, Sirota M, Butte AJ. 2012. Ten years of pathway analysis: Current approaches and outstanding challenges. PLoS Comput Biol 8(2):e1002375.
16. Liu K, Fast S, Zawistowski M, Tintle NL. 2013. A geometric framework for evaluating rare variant tests of association. Genet Epidemiol 37(4):345-357.
17. Michaud J, Simpson KM, Escher R, Buchet-Poyau K, Beissbarth T, Carmichael C, Ritchie ME, Schutz F, Cannon P, Liu M and others. 2008. Integrative analysis of RUNX1 downstream pathways and target genes. BMC Genomics 9:363.
18. Oualkacha K, Dastani Z, Li R, Cingolani PE, Spector TD, Hammond CJ, Richards JB, Ciampi A, Greenwood CM. 2013. Adjusted sequence kernel association test for rare variants controlling for cryptic and family relatedness. Genet Epidemiol 37(4):366-376.
19. Petersen A, Alvarez C, De Claire S, Tintle NL. 2013. Assessing methods for assigning SNPs to genes in gene-based tests of association using common variants. PLoS One 8(5):e62161.
20. Petersen A, Sitarik A, Luedtke A, Powers S, Bekmetjev A, Tintle NL. 2011. Evaluating methods for combining rare variant data in pathway-based tests of genetic association. BMC Proc 5(Suppl 9):S48.
21. Ramanan V, Shen L, Moore J, Saykin A. 2012. Pathway analysis of genomic data: Concepts, methods, and prospects for future development. Tr Genet 28(7):323-332.
22. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498-2504.
23. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES and others. 2005. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545-15550.
24. Tintle N, Aschard H, Hu I, Nock N, Wang H, Pugh E. 2011. Inflated type I error rates when using aggregation methods to analyze rare variants in the 1000 Genomes Project exon sequencing data in unrelated individuals: Summary results from Group 7 at Genetic Analysis Workshop 17. Genet Epidemiol 35(Suppl 1):S56-S60.
25. Tobin MD, Sheehan NA, Scurrah KJ, Burton PR. 2005. Adjusting for treatment effects in studies of quantitative traits: Antihypertensive therapy and systolic blood pressure. Stat Med 24(19):2911-2935.
26. Yang W, Gu C. 2011. Enrichment analysis of genetic association in genes and pathways by aggregating signals from both rare and common variants. BMC Proc 5(Suppl 9):S52.